GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 848 filers reported holding GLAXOSMITHKLINE PLC in Q1 2019. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $24,000 | -40.0% | 560 | -38.5% | 0.01% | -33.3% |
| Q1 2022 | $40,000 | +100.0% | 910 | +100.0% | 0.01% | +125.0% |
| Q4 2021 | $20,000 | +17.6% | 455 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $17,000 | -98.6% | 455 | -98.6% | 0.00% | -98.9% |
| Q2 2021 | $1,197,000 | +7.9% | 31,806 | +2.4% | 0.36% | +38.9% |
| Q1 2021 | $1,109,000 | -7.0% | 31,065 | -4.1% | 0.26% | -13.2% |
| Q4 2020 | $1,192,000 | -0.4% | 32,391 | +1.8% | 0.30% | -17.1% |
| Q3 2020 | $1,197,000 | -13.0% | 31,806 | -5.7% | 0.36% | -18.1% |
| Q2 2020 | $1,376,000 | -2.3% | 33,730 | -9.3% | 0.44% | -9.0% |
| Q1 2020 | $1,409,000 | -16.0% | 37,183 | +4.2% | 0.48% | -0.4% |
| Q4 2019 | $1,677,000 | +12.0% | 35,678 | +1.7% | 0.48% | +3.4% |
| Q3 2019 | $1,497,000 | +9.5% | 35,082 | +2.7% | 0.46% | +7.4% |
| Q2 2019 | $1,367,000 | -3.0% | 34,160 | +1.2% | 0.43% | -6.7% |
| Q1 2019 | $1,410,000 | +6.9% | 33,744 | -2.3% | 0.46% | -2.7% |
| Q4 2018 | $1,319,000 | -0.4% | 34,522 | +4.7% | 0.48% | +15.2% |
| Q3 2018 | $1,324,000 | +0.3% | 32,960 | +0.7% | 0.41% | -4.6% |
| Q2 2018 | $1,320,000 | -2.4% | 32,741 | -5.4% | 0.43% | +3.6% |
| Q1 2018 | $1,352,000 | +54.2% | 34,597 | +39.9% | 0.42% | +43.5% |
| Q4 2017 | $877,000 | -18.0% | 24,729 | -6.0% | 0.29% | -21.7% |
| Q3 2017 | $1,069,000 | -4.6% | 26,319 | +1.3% | 0.37% | -9.9% |
| Q2 2017 | $1,120,000 | +3.9% | 25,974 | +1.6% | 0.41% | -3.9% |
| Q1 2017 | $1,078,000 | -99.9% | 25,564 | -0.2% | 0.43% | +1.2% |
| Q4 2016 | $986,280,000 | +85812.9% | 25,611 | -3.7% | 0.43% | -20.1% |
| Q3 2016 | $1,148,000 | -1.2% | 26,607 | -0.7% | 0.53% | +1.1% |
| Q2 2016 | $1,162,000 | +6.9% | 26,807 | 0.0% | 0.53% | +7.1% |
| Q1 2016 | $1,087,000 | -11.0% | 26,807 | -11.5% | 0.49% | -11.4% |
| Q4 2015 | $1,222,000 | +19.3% | 30,275 | +13.7% | 0.56% | +12.6% |
| Q3 2015 | $1,024,000 | -7.7% | 26,630 | +0.0% | 0.49% | +4.2% |
| Q2 2015 | $1,109,000 | -8.5% | 26,620 | +1.4% | 0.47% | -7.6% |
| Q1 2015 | $1,212,000 | +10.4% | 26,260 | +2.2% | 0.51% | +8.7% |
| Q4 2014 | $1,098,000 | +2.3% | 25,700 | +10.1% | 0.47% | -3.1% |
| Q3 2014 | $1,073,000 | -14.0% | 23,346 | +0.1% | 0.49% | -15.3% |
| Q2 2014 | $1,248,000 | -13.5% | 23,331 | -13.5% | 0.57% | -15.5% |
| Q1 2014 | $1,442,000 | -1.4% | 26,981 | -1.5% | 0.68% | -3.3% |
| Q4 2013 | $1,462,000 | +5.5% | 27,391 | -0.9% | 0.70% | 0.0% |
| Q3 2013 | $1,386,000 | -0.2% | 27,631 | -0.6% | 0.70% | -7.5% |
| Q2 2013 | $1,389,000 | – | 27,796 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |